JP2012509933A - 白花蛇舌草、ダイオウ、コウゾ抽出物を含有する美白用皮膚外用剤組成物 - Google Patents
白花蛇舌草、ダイオウ、コウゾ抽出物を含有する美白用皮膚外用剤組成物 Download PDFInfo
- Publication number
- JP2012509933A JP2012509933A JP2011538546A JP2011538546A JP2012509933A JP 2012509933 A JP2012509933 A JP 2012509933A JP 2011538546 A JP2011538546 A JP 2011538546A JP 2011538546 A JP2011538546 A JP 2011538546A JP 2012509933 A JP2012509933 A JP 2012509933A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- white flower
- whitening
- sorghum
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000284 extract Substances 0.000 title claims abstract description 112
- 244000025254 Cannabis sativa Species 0.000 title claims abstract description 50
- 230000002087 whitening effect Effects 0.000 title claims abstract description 40
- 239000000203 mixture Substances 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 241001261543 Orthriophis moellendorffi Species 0.000 title claims description 14
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 claims abstract description 55
- 239000004480 active ingredient Substances 0.000 claims abstract description 16
- 240000006248 Broussonetia kazinoki Species 0.000 claims abstract description 7
- 235000006716 Broussonetia kazinoki Nutrition 0.000 claims abstract description 7
- 229940030961 sorghum extract Drugs 0.000 claims description 15
- 240000000249 Morus alba Species 0.000 claims description 11
- 235000008708 Morus alba Nutrition 0.000 claims description 11
- 230000002401 inhibitory effect Effects 0.000 abstract description 8
- 230000008099 melanin synthesis Effects 0.000 abstract description 8
- 239000002537 cosmetic Substances 0.000 abstract description 7
- 239000002994 raw material Substances 0.000 abstract description 5
- 210000003491 skin Anatomy 0.000 description 33
- 240000006394 Sorghum bicolor Species 0.000 description 26
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 26
- 238000004519 manufacturing process Methods 0.000 description 15
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 12
- 235000016709 nutrition Nutrition 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 230000009471 action Effects 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- 239000006210 lotion Substances 0.000 description 7
- 102000003425 Tyrosinase Human genes 0.000 description 6
- 108060008724 Tyrosinase Proteins 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 230000035764 nutrition Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 241000219061 Rheum Species 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 239000000049 pigment Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 241000270295 Serpentes Species 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 208000012641 Pigmentation disease Diseases 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 3
- 235000013365 dairy product Nutrition 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- YDQWDHRMZQUTBA-UHFFFAOYSA-N Aloe emodin Chemical compound C1=CC=C2C(=O)C3=CC(CO)=CC(O)=C3C(=O)C2=C1O YDQWDHRMZQUTBA-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229940076810 beta sitosterol Drugs 0.000 description 2
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000002752 melanocyte Anatomy 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 238000005191 phase separation Methods 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 229940112950 sage extract Drugs 0.000 description 2
- 235000020752 sage extract Nutrition 0.000 description 2
- 229950005143 sitosterol Drugs 0.000 description 2
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 1
- QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 description 1
- CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 description 1
- 241000705930 Broussonetia papyrifera Species 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 229920000296 Glucogallin Polymers 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 240000001659 Oldenlandia diffusa Species 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- JYDNKGUBLIKNAM-UHFFFAOYSA-N Oxyallobutulin Natural products C1CC(=O)C(C)(C)C2CCC3(C)C4(C)CCC5(CO)CCC(C(=C)C)C5C4CCC3C21C JYDNKGUBLIKNAM-UHFFFAOYSA-N 0.000 description 1
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 1
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- 235000008081 Rheum officinale Nutrition 0.000 description 1
- 244000193032 Rheum rhaponticum Species 0.000 description 1
- 241000976858 Rheum tanguticum Species 0.000 description 1
- 241001107098 Rubiaceae Species 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- GDVRUDXLQBVIKP-UHFFFAOYSA-N beta-D-glucogallin Natural products OC1C(O)C(O)C(CO)OC1OC(=O)C1=CC(O)=C(O)C(O)=C1 GDVRUDXLQBVIKP-UHFFFAOYSA-N 0.000 description 1
- FVWJYYTZTCVBKE-ROUWMTJPSA-N betulin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(CO)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C FVWJYYTZTCVBKE-ROUWMTJPSA-N 0.000 description 1
- MVIRREHRVZLANQ-UHFFFAOYSA-N betulin Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C2CC=C4C5C(CCC5(CO)CCC34C)C(=C)C)C1(C)C MVIRREHRVZLANQ-UHFFFAOYSA-N 0.000 description 1
- QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000003366 colagenolytic effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- KGHSLXLLBHRMML-VKISENBKSA-N glucogallin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](OC)O[C@H]1OC(=O)C1=CC(O)=C(O)C(O)=C1 KGHSLXLLBHRMML-VKISENBKSA-N 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- 239000008057 potassium phosphate buffer Substances 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229940092385 radish extract Drugs 0.000 description 1
- 206010038038 rectal cancer Diseases 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- -1 rhein Chemical compound 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 208000031019 skin pigmentation disease Diseases 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
乾燥した白花蛇舌草の全草1kgを精製水10Lに加えた後、沸騰するまで加熱し、10分間さらに加熱した後、水を除去し、洗浄後、別途精製水10Lを加えて再度洗浄した。残留物を風で乾かした後、70%エタノール20Lに加えてから、還流装置を接続した後、加温して24時間還流抽出した。80メッシュの篩を利用して固形分を除去した後、残った濾液を再度濾過した後、減圧濃縮器を利用して濾液中の溶媒を蒸留除去し、約50gの緑色の固形物を得た。
コウゾの茎及び根1kgをきれいな水で洗って乾燥させた後、水10Lに入れ、冷却コンデンサ付き抽出機で5時間煮込んで抽出した後、300メッシュの濾過布で濾過し、5〜15℃で5日間放置して熟成させた後、濾紙で濾過した。この抽出物を冷却コンデンサ付き蒸留装置で減圧濃縮し、約70gの固形物を得た。
乾燥したダイオウ1kgに95%以上メタノール4Lを入れ、常温で1日放置して抽出する。前記工程を2回繰り返して抽出液を得、抽出液を濾過した後、その濾液を真空濃縮器で濃縮して乾固物400gを得た。前記乾固物400gに水1Lとエチルアセテート2Lを加え、常温で2時間攪拌した後、静置して相分離させた。相分離がされた後、境界層又はエチルアセテート層に生成された結晶化物のみを得るために、水の層を削除した後、エチルアセテートをさらに2L添加した。前記工程を2回繰り返して十分に洗浄し、濾過した後、濾過物を真空オーブンで乾燥し、ダイオウ抽出物約30gを得た。
製造例1〜3で得たそれぞれの抽出物を、白花蛇舌草:ダイオウ:コウゾ=1:1:1の重量比で混合した。
製造例1及び製造例2で得たそれぞれの抽出物を、白花蛇舌草:コウゾ=1:1の重量比で混合した。
製造例1及び製造例3で得たそれぞれの抽出物を、白花蛇舌草:ダイオウ=1:1の重量比で混合した。
製造例1〜製造例3で得たそれぞれの抽出物を、単独で使用した。
1)実験方法
酵素チロシナーゼは、キノコ類(Mushroom)から抽出されたもので、シグマ(SIGMA)社のものを使用した。まず、基質のチロシンを蒸留水に溶解させて0.3mg/mLの溶液にし、その溶液を1.0mLずつ試験管に入れて、ここにリン酸カリウム緩衝液(0.1モル濃度、pH6.8)1.0mL及び蒸留水0.7mLを加えて、混合溶液を形成した。実施例及び比較例の各抽出物を、エタノール溶液に適当な濃度でそれぞれ含有させた0.2mLの抽出物試料液を前記混合溶液にそれぞれ入れた後、37℃恒温槽で10分間反応させた。このとき、対照群は、実施例及び比較例の各抽出物試料の代わりに溶媒のみを0.2mL入れる。この反応液に、2500ユニット/mLのチロシナーゼ溶液0.1mLずつを入れ、再び37℃恒温槽で10分間反応させた。次いで、前記反応液の入った試験管を氷水の中に入れ、急冷させて反応を中止させ、光電分光分析計で波長475nmでの吸光度を測定した。その後、実施例及び比較例の各抽出物の下式1によるチロシナーゼ阻害効果、すなわち、メラニン生成抑制率を計算し、その結果を表1に示した。
メラニン生成抑制率(inhibition)(%)=[(A−B)/A]×100
A:試験物質(inhibitor)を添加した培地で培養した細胞の吸光度
B:試験物質を添加していない条件で培養した細胞の吸光度
健康な12人の男性を対象に、被験者の上腕部位に、縦横各1.5cmの正方形の穴が空いた不透明テープを貼付した後、各被験者の最小紅斑量(Minimal Erythema Dose)の1.5〜2倍程度の紫外線(UVB)を照射して、肌の黒化を誘導した。
ΔL*=塗布終了時点におけるL*値−塗布開始時のL*値
下記表3に記載の組成により通常的な方法で栄養化粧水を製造した。白花蛇舌草、ダイオウ及びコウゾの抽出物の代わりに、白花蛇舌草及びダイオウの抽出物や、白花蛇舌草及びコウゾの抽出物に置き換えて製造することができる。
下記表4に記載の組成により通常的な方法で栄養ローションを製造した。白花蛇舌草、ダイオウ及びコウゾの抽出物の代わりに、白花蛇舌草及びダイオウの抽出物や、白花蛇舌草及びコウゾの抽出物に置き換えて製造することができる。
下記表5に記載の組成により通常的な方法で栄養クリームを製造した。白花蛇舌草、ダイオウ及びコウゾの抽出物の代わりに、白花蛇舌草及びダイオウの抽出物や、白花蛇舌草及びコウゾの抽出物に置き換えて製造することができる。
下記表6に記載の組成により通常的な方法でマッサージクリームを製造した。白花蛇舌草、ダイオウ及びコウゾの抽出物の代わりに、白花蛇舌草及びダイオウの抽出物や、白花蛇舌草及びコウゾの抽出物に置き換えて製造することができる。
下記表7に記載の組成により通常的な方法でパックを製造した。白花蛇舌草、ダイオウ及びコウゾの抽出物の代わりに、白花蛇舌草及びダイオウの抽出物や、白花蛇舌草及びコウゾの抽出物に置き換えて製造することができる。
下記表8に記載の組成により通常的な方法で軟膏を製造した。白花蛇舌草、ダイオウ及びコウゾの抽出物の代わりに、白花蛇舌草及びダイオウの抽出物や、白花蛇舌草及びコウゾの抽出物に置き換えて製造することができる。
Claims (4)
- 白花蛇舌草抽出物と、ダイオウ抽出物及びコウゾ抽出物のいずれか1つ以上を有効成分として含有する、美白用皮膚外用剤組成物。
- 有効成分として白花蛇舌草抽出物及びダイオウ抽出物を含有し、
前記白花蛇舌草抽出物及びダイオウ抽出物は、1〜4:1〜4の重量比で含有することを特徴とする、請求項1記載の美白用皮膚外用剤組成物。 - 有効成分として白花蛇舌草抽出物及びコウゾ抽出物を含有し、
前記白花蛇舌草抽出物及びコウゾ抽出物は、1〜4:1〜4の重量比で含有することを特徴とする、請求項1記載の美白用皮膚外用剤組成物。 - 有効成分として白花蛇舌草抽出物、ダイオウ抽出物及びコウゾ抽出物を含有し、
前記白花蛇舌草抽出物、ダイオウ抽出物及びコウゾ抽出物は、1〜4:1〜4:1〜4の重量比で含有することを特徴とする、請求項1記載の美白用皮膚外用剤組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2008-0117660 | 2008-11-25 | ||
KR1020080117660A KR101600957B1 (ko) | 2008-11-25 | 2008-11-25 | 백화사설초, 대황, 닥나무 추출물을 함유하는 미백용 피부외용제 조성물 |
PCT/KR2009/006883 WO2010062087A2 (en) | 2008-11-25 | 2009-11-23 | Whitening composition for external skin application containing oldenlandia diffusa willd, rheum undulatum, and broussonetia kazinoki extract |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2012509933A true JP2012509933A (ja) | 2012-04-26 |
JP5685194B2 JP5685194B2 (ja) | 2015-03-18 |
Family
ID=42226234
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011538546A Active JP5685194B2 (ja) | 2008-11-25 | 2009-11-23 | 白花蛇舌草、ダイオウ、コウゾ抽出物を含有する美白用皮膚外用剤組成物 |
Country Status (5)
Country | Link |
---|---|
US (1) | US8647683B2 (ja) |
JP (1) | JP5685194B2 (ja) |
KR (1) | KR101600957B1 (ja) |
CN (1) | CN102405040B (ja) |
WO (1) | WO2010062087A2 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2020103077A (ja) * | 2018-12-26 | 2020-07-09 | 武田コンシューマーヘルスケア株式会社 | 血圧降下用組成物 |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011159098A2 (ko) * | 2010-06-18 | 2011-12-22 | (주)아모레퍼시픽 | 닥나무 추출물 제조 방법 |
KR101831366B1 (ko) | 2010-06-18 | 2018-04-04 | (주)아모레퍼시픽 | 닥나무 추출물 제조 방법 |
KR101681683B1 (ko) * | 2010-07-02 | 2016-12-01 | (주)아모레퍼시픽 | 닥나무의 꽃과 열매 추출물을 함유하는 피부 미백용 피부 외용제 조성물 |
KR101694483B1 (ko) * | 2010-07-05 | 2017-01-10 | (주)아모레퍼시픽 | 닥나무 추출물을 함유하는 백모 방지용 및 백반증 치료용 조성물 |
KR101800213B1 (ko) * | 2010-07-02 | 2017-11-24 | (주)아모레퍼시픽 | 청시닥나무, 개시닥나무 또는 시닥나무의 추출물을 함유하는 피부 미백용 화장료 조성물 |
WO2012002784A2 (ko) * | 2010-07-02 | 2012-01-05 | (주)아모레퍼시픽 | 닥나무 추출물을 함유하는 조성물 |
KR101796694B1 (ko) * | 2010-11-30 | 2017-11-13 | (주)아모레퍼시픽 | 피부 미백 및 탄력 제고 화장료 조성물 |
KR102700128B1 (ko) * | 2016-11-29 | 2024-08-28 | 주식회사 엘지생활건강 | 퀘르세틴-3-o-소포로사이드를 포함하는 화장료 조성물 |
KR102178096B1 (ko) * | 2018-12-14 | 2020-11-12 | (주)아마란스 | 아마란스 추출물을 유효성분으로 포함하는 피부 미백용 조성물 |
KR20210138394A (ko) | 2020-05-12 | 2021-11-19 | 코스맥스바이오 주식회사 | 산나물 추출물을 유효성분으로 하는 피부 미백용 조성물 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0624937A (ja) * | 1992-06-29 | 1994-02-01 | Narisu Keshohin:Kk | ムコ多糖類断片化抑制剤、活性酸素消去剤、抗酸化剤および化粧料。 |
US5766614A (en) * | 1997-03-20 | 1998-06-16 | Yong; Liu | Burn treatment compositions containing herbal mix |
JP2000281528A (ja) * | 1999-03-31 | 2000-10-10 | Ichimaru Pharcos Co Ltd | 化粧料組成物 |
KR20060121496A (ko) * | 2005-05-24 | 2006-11-29 | 학교법인 성균관대학 | 애기닥나무 추출물을 포함하는 미백용 조성물 |
JP2007269752A (ja) * | 2006-03-31 | 2007-10-18 | Naris Cosmetics Co Ltd | 皮膚外用剤 |
CN101406547A (zh) * | 2008-11-11 | 2009-04-15 | 孙立华 | 治疗粉刺的面膜 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR930010548B1 (ko) * | 1991-05-27 | 1993-10-28 | 주식회사 태평양 | 닥나무 추출물을 함유한 미백화장료 |
KR100896697B1 (ko) * | 2004-04-09 | 2009-05-14 | (주)아모레퍼시픽 | 고압유화기술에 의한 대황추출물의 경피흡수 촉진방법 및이를 응용한 미백용 피부 외용제 조성물 |
CN100496451C (zh) | 2004-10-22 | 2009-06-10 | 卢藏田 | 复合美白祛斑液 |
JP2007106675A (ja) * | 2005-10-11 | 2007-04-26 | Shiseido Co Ltd | 美白剤 |
DE102006015575A1 (de) * | 2006-04-03 | 2007-10-04 | Hochschule Anhalt (Fh) | Antioxidative Wirkstofffraktionen für kosmetische Formulierungen |
DE102006015574A1 (de) * | 2006-04-03 | 2007-10-04 | Esa Patentverwertungsagentur Sachsen-Anhalt Gmbh | Wirkstofffraktionen für Formulierungen zur Therapie und Prävention von entzündlichen Erkrankungen |
KR100792629B1 (ko) * | 2006-11-20 | 2008-01-09 | (주)아모레퍼시픽 | 나노리포좀으로 안정화된 백화사설초 추출물을 함유하는피부 미백용 화장료 조성물 |
-
2008
- 2008-11-25 KR KR1020080117660A patent/KR101600957B1/ko active IP Right Grant
-
2009
- 2009-11-23 US US13/130,992 patent/US8647683B2/en active Active
- 2009-11-23 WO PCT/KR2009/006883 patent/WO2010062087A2/en active Application Filing
- 2009-11-23 JP JP2011538546A patent/JP5685194B2/ja active Active
- 2009-11-23 CN CN200980142720.9A patent/CN102405040B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0624937A (ja) * | 1992-06-29 | 1994-02-01 | Narisu Keshohin:Kk | ムコ多糖類断片化抑制剤、活性酸素消去剤、抗酸化剤および化粧料。 |
US5766614A (en) * | 1997-03-20 | 1998-06-16 | Yong; Liu | Burn treatment compositions containing herbal mix |
JP2000281528A (ja) * | 1999-03-31 | 2000-10-10 | Ichimaru Pharcos Co Ltd | 化粧料組成物 |
KR20060121496A (ko) * | 2005-05-24 | 2006-11-29 | 학교법인 성균관대학 | 애기닥나무 추출물을 포함하는 미백용 조성물 |
JP2007269752A (ja) * | 2006-03-31 | 2007-10-18 | Naris Cosmetics Co Ltd | 皮膚外用剤 |
CN101406547A (zh) * | 2008-11-11 | 2009-04-15 | 孙立华 | 治疗粉刺的面膜 |
Non-Patent Citations (1)
Title |
---|
JPN6014005990; 'Ok-sub Lee, Eun-Joung Kim' Cosmetics & Toiletries Vol.110, 1995, p.51-56 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2020103077A (ja) * | 2018-12-26 | 2020-07-09 | 武田コンシューマーヘルスケア株式会社 | 血圧降下用組成物 |
JP7253372B2 (ja) | 2018-12-26 | 2023-04-06 | アリナミン製薬株式会社 | 血圧降下用組成物 |
Also Published As
Publication number | Publication date |
---|---|
KR101600957B1 (ko) | 2016-03-09 |
WO2010062087A2 (en) | 2010-06-03 |
CN102405040A (zh) | 2012-04-04 |
KR20100059033A (ko) | 2010-06-04 |
US8647683B2 (en) | 2014-02-11 |
WO2010062087A3 (en) | 2010-09-10 |
US20110274635A1 (en) | 2011-11-10 |
JP5685194B2 (ja) | 2015-03-18 |
CN102405040B (zh) | 2014-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5685194B2 (ja) | 白花蛇舌草、ダイオウ、コウゾ抽出物を含有する美白用皮膚外用剤組成物 | |
KR20210038369A (ko) | 한방생물 추출물을 포함하는 탈모방지 및 발모용 세정제 조성물 및 이의 제조방법 | |
WO2003084302A2 (fr) | Agent anti-vieillissement | |
JP5905878B2 (ja) | コウゾの花および実の抽出物を含有する皮膚美白用の皮膚外用剤組成物 | |
KR20090131399A (ko) | 항염 및 피부자극완화 효과가 있는 천연 식물의혼합추출물을 함유하는 화장료 조성물 | |
KR102233117B1 (ko) | 까실쑥부쟁이 추출물을 포함하는 육모 촉진 또는 탈모 방지용 조성물 | |
JP3632347B2 (ja) | 皮膚化粧料 | |
KR100454736B1 (ko) | 베라트라민을 함유하는 피부미백용 조성물 | |
KR100789632B1 (ko) | 멜라닌 생성 억제 활성을 갖는 식물 추출물을 함유하는피부미백용 화장료 | |
KR101837422B1 (ko) | 진세노사이드 f1과 닥나무 추출물 또는 백화사설초 추출물을 함유하는 화장료 조성물 | |
KR20020029182A (ko) | 여로 추출물, 위릉채 추출물에서 선택되는 1종 이상을유효성분으로 함유하는 화장료 조성물 | |
JP6030450B2 (ja) | 白米蒸法を利用した漢方成分抽出方法 | |
JP2008280249A (ja) | 美白化粧料 | |
KR101310655B1 (ko) | 마름 추출물을 유효성분으로 포함하는 화장료 조성물 및 그 제조 방법 | |
KR20030064107A (ko) | 백화사설초 추출물을 함유하는 피부 외용제 조성물 | |
KR101107311B1 (ko) | 퓨라노디에논을 포함하는 피부미백용 조성물 | |
JP2005015450A (ja) | 皮膚化粧料 | |
KR20160003916A (ko) | 한약재 추출물을 포함하는 미백 또는 안색 개선용 화장료 조성물 | |
KR100431271B1 (ko) | 아레콜린을 함유하는 피부미백용 조성물 | |
KR20040059005A (ko) | 멜라닌 생성 억제 활성을 갖는 식물 추출물을 함유하는피부미백용 화장료 | |
KR20040059004A (ko) | 멜라닌 생성 억제 활성을 갖는 식물 추출물을 함유하는피부미백용 화장료 | |
KR100789633B1 (ko) | 멜라닌 생성 억제 활성을 갖는 식물 추출물을 함유하는피부미백용 화장료 | |
JP2007191438A (ja) | デスモソーム分解促進剤 | |
KR20040059007A (ko) | 멜라닌 생성 억제 활성을 갖는 식물 추출물을 함유하는피부미백용 화장료 | |
JP2004182709A (ja) | 皮膚外用剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20121101 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20140206 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140212 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140502 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20141225 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20150116 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5685194 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |